LXRX
Lexicon Pharmaceuticals·NASDAQ
--
--(--)
--
--(--)
3.95 / 10
Netural
Lexicon Pharmaceuticals' fundamental evaluation scores 4.0/10, indicating subpar financial health. Key positives include favorable PB-ROE, Revenue-MV, Profit-MV, and Cash-MV metrics, but significant drawbacks are evident in the Current assets turnover ratio and Fixed assets turnover ratio. The Gross profit margin is exceptionally high at 99.8353%, yet the Net profit / Total profit ratio of 100.0000 offers limited insight. Overall, the fundamentals present a challenging profile that warrants careful consideration.
Analysis Checks(6/10)
Revenue-MV
Value-1.68
Score2/3
Weight26.06%
1M Return11.69%
Value-1.68
Score2/3
Weight26.06%
1M Return11.69%
Gross profit margin (%)
Value99.84
Score2/3
Weight2.83%
1M Return1.47%
Value99.84
Score2/3
Weight2.83%
1M Return1.47%
PB-ROE
Value1.33
Score3/3
Weight26.85%
1M Return11.47%
Value1.33
Score3/3
Weight26.85%
1M Return11.47%
Fixed assets turnover ratio
Value19.85
Score1/3
Weight-2.71%
1M Return-1.64%
Value19.85
Score1/3
Weight-2.71%
1M Return-1.64%
Cash-MV
Value-0.07
Score2/3
Weight17.12%
1M Return7.73%
Value-0.07
Score2/3
Weight17.12%
1M Return7.73%
Inventory turnover ratio
Value0.38
Score2/3
Weight-4.34%
1M Return-2.63%
Value0.38
Score2/3
Weight-4.34%
1M Return-2.63%
Profit-MV
Value0.46
Score2/3
Weight17.10%
1M Return7.79%
Value0.46
Score2/3
Weight17.10%
1M Return7.79%
Current assets turnover ratio
Value0.24
Score0/3
Weight-3.13%
1M Return-1.88%
Value0.24
Score0/3
Weight-3.13%
1M Return-1.88%
Asset-MV
Value-0.50
Score1/3
Weight20.73%
1M Return8.74%
Value-0.50
Score1/3
Weight20.73%
1M Return8.74%
Net profit / Total profit (%)
Value100.00
Score0/3
Weight-0.51%
1M Return-0.30%
Value100.00
Score0/3
Weight-0.51%
1M Return-0.30%
Revenue-MV
Value-1.68
Score2/3
Weight26.06%
1M Return11.69%
Value-1.68
Score2/3
Weight26.06%
1M Return11.69%
Inventory turnover ratio
Value0.38
Score2/3
Weight-4.34%
1M Return-2.63%
Value0.38
Score2/3
Weight-4.34%
1M Return-2.63%
Gross profit margin (%)
Value99.84
Score2/3
Weight2.83%
1M Return1.47%
Value99.84
Score2/3
Weight2.83%
1M Return1.47%
Profit-MV
Value0.46
Score2/3
Weight17.10%
1M Return7.79%
Value0.46
Score2/3
Weight17.10%
1M Return7.79%
PB-ROE
Value1.33
Score3/3
Weight26.85%
1M Return11.47%
Value1.33
Score3/3
Weight26.85%
1M Return11.47%
Current assets turnover ratio
Value0.24
Score0/3
Weight-3.13%
1M Return-1.88%
Value0.24
Score0/3
Weight-3.13%
1M Return-1.88%
Fixed assets turnover ratio
Value19.85
Score1/3
Weight-2.71%
1M Return-1.64%
Value19.85
Score1/3
Weight-2.71%
1M Return-1.64%
Asset-MV
Value-0.50
Score1/3
Weight20.73%
1M Return8.74%
Value-0.50
Score1/3
Weight20.73%
1M Return8.74%
Cash-MV
Value-0.07
Score2/3
Weight17.12%
1M Return7.73%
Value-0.07
Score2/3
Weight17.12%
1M Return7.73%
Net profit / Total profit (%)
Value100.00
Score0/3
Weight-0.51%
1M Return-0.30%
Value100.00
Score0/3
Weight-0.51%
1M Return-0.30%
Is LXRX undervalued or overvalued?
- LXRX scores 3.95/10 on fundamentals and holds a Fair valuation at present. Backed by its -26.16% ROE, -96.77% net margin, -7.09 P/E ratio, 4.05 P/B ratio, and 74.32% earnings growth, these metrics solidify its Netural investment rating.
